PolyPid
3.48
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About PolyPid
PolyPid Ltd., una compañía biofarmacéutica en etapa avanzada, desarrolla, fabrica y comercializa productos basados en la plataforma de matriz de encapsulación de polímeros y lípidos (PLEX) para abordar las necesidades médicas no cubiertas. Su producto principal candidato es D-PLEX100, que se encuentra en un ensayo clínico de fase III para la prevención de infecciones del sitio quirúrgico (ISQ) del esternón (hueso), así como para la prevención de las ISQ abdominales (tejidos blandos). PolyPid Ltd. se incorporó en 2008 y tiene su sede en Petah Tikva, Israel.
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.